Logo image of CRGX

CARGO THERAPEUTICS INC (CRGX) Stock Analyst Ratings

NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD

3.75  -0.01 (-0.27%)

Buy % Consensus

53

ChartMill assigns a Buy % Consensus number of 53% to CRGX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 12.92. This target is 244.53% above the current price.
CRGX was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about CRGX.
In the last month the buy percentage fell by 31 points. So the trust of analysts is decreasing.
CRGX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
CRGX Historical Analyst RatingsCRGX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10

Price Target & Forecast

Price Low Median Mean High 3.753.035.6112.9231.50 - -19.20% 49.60% 244.53% 740.00%
CRGX Current Analyst RatingCRGX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-30 Chardan Capital Downgrade Buy -> Neutral
2025-01-30 William Blair Downgrade Outperform -> Market Perform
2025-01-30 Truist Securities Downgrade Buy -> Hold
2025-01-30 JP Morgan Downgrade Overweight -> Underweight
2025-01-30 Piper Sandler Downgrade Overweight -> Neutral
2025-01-30 Jefferies Downgrade Buy -> Hold
2025-01-30 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-11-26 William Blair Initiate Outperform
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-13 Chardan Capital Maintains Buy -> Buy
2024-08-13 Piper Sandler Maintains Overweight -> Overweight
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-22 HC Wainwright & Co. Initiate Buy
2024-07-08 Chardan Capital Initiate Buy
2024-06-27 Piper Sandler Initiate Overweight
2024-05-16 Truist Securities Reiterate Buy -> Buy
2023-12-05 TD Cowen Initiate Outperform
2023-12-05 Truist Securities Initiate Buy
2023-12-05 JP Morgan Initiate Overweight
2023-12-05 Jefferies Initiate Buy